New book by Larry Connors Click here Improve your trading - See how
Siemens Healthcare, a medical solutions provider and a divisions of Siemens AG (NYSE:SI), announced on Sunday (30 November), the unveiling of its new Tim (Total imaging matrix) technology and dedicated breast scanner at the 2008 Radiological Society of North America (RSNA) annual meeting being held in Chicago, US.
The company's 'syngo TimCT Oncology' joins Siemens' comprehensive Oncology Solutions and offers continuous table movement for extended Field of View (FoV) imaging and comprehensive staging for increased workflow.
Siemens also plans to introduce new dedicated breast coils for all customer needs. On the 1.5 Tesla Tim systems and 3 Tesla Tim systems, the modular and versatile concept of the BI (Biopsy and Imaging) and AI (Advanced Imaging) coils makes it possible to customise them. The AI breast coil will be available with 16 RF channels for high acceleration factors and advanced imaging.
The second new breast coil for imaging and biopsy on the 1.5 Tesla Tim systems is the Sentinelle Vanguard for Siemens. The coil is designed with variable coil geometry (VCG) that allows the coil to accommodate a wide range of patient sizes, increases patient comfort and increases signal-to-noise ratio, ultimately delivering excellent image quality with 8 RF channels.
In addition, the company will introduce the 'syngo GRACE 3T' , reportedly the first quantitative MR breast spectroscopy in the industry. The syngo GRACE 3T monitors choline, acting as a biomarker and provides valuable information on the biochemical composition of breast lesions, Siemens said.
Also, the company's new 1.5T MAGNETOM Espree - Pink, the next-generation breast MRI system, is being displayed at the RSNA. MAGNETOM Espree - Pink combines the 70cm Open-Bore design of the MAGNETOM Espree with the Sentinelle Vanguard solution. This breast coil offers exceptional breast imaging and biopsy access, and provides patient comfort, unique applications and an innovative workflow 'pushing MRI Breast Care to the next level', according to the company.
Comments on this story may be sent to admin@m2.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
